½ÃÀ庸°í¼­
»óǰÄÚµå
1595520

¼¼°èÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå : Áúȯ À¯Çü, ±â¼ú, Á¦Çüº° ¿¹Ãø(2025-2030³â)

Poultry Vaccine Market by Disease Type (Infectious Bronchitis, Marek¢¥s Disease, New Castle Disease), Technology (Inactivated, Live Attenuated Vaccines, Recombinant), Dosage Form - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°¡±Ý¿ë ¹é½Å ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 20¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 22¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 7.86%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 35¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°¡±Ý·ù ¹é½Å ½ÃÀåÀÇ ¹üÀ§´Â Á¶·ù ÀÎÇ÷翣ÀÚ, ´ºÄ³½½º´, Àü¿°¼º ±â°üÁö¿° µîÀÇ °¡±Ý·ù °¨¿° ¿¹¹æÀ» ¸ñÀûÀ¸·Î ÇÑ ¹é½ÅÀÇ °³¹ß, »ý»ê, À¯ÅëÀ» Æ÷ÇÔÇÕ´Ï´Ù. È®º¸ÇÏ°í ½Ä·® ¾Èº¸¸¦ °­È­ÇÏ°í °¡±Ý·ù »ê¾÷ÀÇ °æÁ¦Àû ¾ÈÁ¤À» Áö¿øÇÕ´Ï´Ù. ¶ÇÇÑ °¡±Ý·ù ¹é½ÅÀÇ Çʿ伺Àº °¡±Ý·ù°¡ °¨¿°¿¡ °É¸®±â ½±°í °æÁ¦ÀûÀ¸·Î Å« ¼Õ½ÇÀ» ÃÊ·¡Çϰí À½½Ä °ø±ÞÀ» À§ÅÂ·Ó°Ô ÇÒ ¼ö ÀÖ´Ù´Â Á¡¿¡¼­ ºÐ¸íÇÕ´Ï´Ù. ÃÖÁ¾ ¿ëµµ´Â »ó¾÷ ¾ç°èÀå, ºÎÈ­Àå, µ¿¹° º´¿ø µî ±¤¹üÀ§ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ (2023³â) 20¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 22¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 35¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 7.86%

ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â °¡±ÝÁúȯÀÇ ¹ß»ý·ü Áõ°¡, ´Ü¹éÁú¿øÀ¸·Î¼­ÀÇ °¡±Ý·ù ¼ö¿ä Áõ°¡, ÀçÁ¶ÇÕ ¹é½Å ¹× ĸ½¶È­¹ý µî ¹é½Å Àü´Þ ±â¼úÀÇ Áøº¸°¡ Æ÷ÇԵ˴ϴÙ. ¹ÙÀÌ¿À º¸¾È ´ëÃ¥ ¿¡ ÁßÁ¡À» µÐ °Íµé°ú À¯±â³ó¾÷ÀÇ µ¿ÇâÀÌ ³ô¾ÆÁö±â ¶§¹®¿¡ °ß°íÇÑ Áúº´ ¿¹¹æ ½Ã½ºÅÛÀÌ ÇÊ¿äÇÕ´Ï´Ù. °³¹ß¿¡ ÅõÀÚÇØ¾ß ÇÑ´Ù´Â °ÍÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå °³Ã´À» ¸·´Â °úÁ¦·Î´Â ¾ö°ÝÇÑ ±ÔÁ¦ Á¤Ã¥, ¹é½Å °³¹ß¿¡ µû¸¥ °íºñ¿ë, ¹é½Å À¯ÅëÀ» À§ÇÑ ÄݵåüÀÎ ¹°·ù µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

±â¼ú Çõ½Å°ú ¿¬±¸´Â Á¦Á¶±â°£ÀÌ ÂªÀº ¹é½ÅÀÇ °³¹ß°ú Àΰ£¿ë ¹é½ÅÀ¸·Î °¢±¤¹Þ°í ÀÖ´Â mRNA ±â¼ú°ú °°Àº ½Å±Ô ±â¹ýÀÇ Å½±¸¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. ¾÷¹«¸¦ °£¼ÒÈ­ÇÏ°í ¹é½ÅÀÇ ¿µÇâ Æò°¡¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐÀº ¿ªµ¿ÀûÀÌ¸ç ¼±ÁøÀû °æÀï°ú ±ÔÁ¦ ´ç±¹ÀÇ ¸ð´ÏÅ͸µÀÌ Æ¯Â¡ÀÔ´Ï´Ù. À¯¸®ÇÑ À§Ä¡¿¡ ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â °¡±Ý¿ë ¹é½Å ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

°¡±Ý¿ë ¹é½Å ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • µ¿¹° Áúº´ÀÇ ¹ß»ý·ü Áõ°¡
    • ¼¼°èÀÇ µ¿¹° ¹é½ÅÁ¢Á¾¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶
    • ¼¼°èÀÇ °¡±Ý ´Ü¹éÁúÀÇ ¼Òºñ·® Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • À§Á¶ ÀǾàǰÀÇ ÀÌ¿ë °¡´É¼º
  • ½ÃÀå ±âȸ
    • ¹é½Å Á¦Á¶ ±â¼úÀÇ Áøº¸
    • ½ÄǰÀÇ ¾ÈÀü¼ºÀ» ³ôÀ̱â À§ÇÑ Áö¼ÓÀûÀÎ ¸ñÀû°ú Á¤ºÎÀÇ Àû±ØÀûÀÎ ´ëó
  • ½ÃÀåÀÇ °úÁ¦
    • ¾ö°ÝÇÑ ±ÔÁ¦ ½ÂÀÎ ¹× ±ÔÁ¤ Áؼö¿¡ ´ëÇÑ ¿ì·Á
    • ¼öÀÇÇÐ °Ë»ç ¹× ¼­ºñ½ºÀÇ ³ôÀº ºñ¿ë

Porter's Five Force : °¡±Ý·ù ¹é½Å ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : °¡±Ý·ù ¹é½Å ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº °¡±Ý·ù ¹é½Å ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹ÃøÇÒ ¼ö ÀÖ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾ú½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : °¡±Ý·ù ¹é½Å ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

°¡±Ý·ù ¹é½Å ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. °ø°³ ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁß, ºÎ¹®È­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­µÇ´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Âµ¥ ÇÊ¿äÇÑ Áö°ßÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : °¡±Ý·ù ¹é½Å ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸®½º´Â °¡±Ý·ù ¹é½Å ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: °¡±Ý·ù ¹é½Å ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

°¡±Ý·ù ¹é½Å ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ¸¶·ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡µµ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • µ¿¹°ÀÇ Áúº´ ¹ß»ý·ü Áõ°¡
      • µ¿¹° ¹é½Å Á¢Á¾¿¡ °üÇÑ ÀǽÄÀÌ ¼¼°èÀûÀ¸·Î ³ô¾ÆÁø´Ù
      • Àü ¼¼°è¿¡¼­ ´ß°í±â ´Ü¹éÁúÀÇ ¼Òºñ°¡ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • À§Á¶ ÀǾàǰÀÇ ÀÌ¿ë °¡´É¼º
    • ±âȸ
      • ¹é½Å Á¦Á¶¿¡ À־ÀÇ ±â¼úÀÇ Áøº¸
      • ½ÄǰÀÇ ¾ÈÀü¼º Çâ»óÀ» À§ÇÑ Áö¼ÓÀûÀÎ ¸ñÇ¥¿Í Á¤ºÎÀÇ ¹Ù¶÷Á÷ÇÑ ´ëó
    • °úÁ¦
      • ¾ö°ÝÇÑ ±ÔÁ¦ ½ÂÀÎ ¹× ÄÄÇöóÀ̾𽺠¿ì·Á
      • ¼öÀÇ»ç °Ë»ç¿Í ¼­ºñ½ºÀÇ °íºñ¿ë
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå °¡±Ý¿ë ¹é½Å ½ÃÀå : Áúȯ À¯Çüº°

  • ¼Ò°³
  • °¨¿°¼º ±â°üÁö¿°
  • ¸¶·ºº´
  • ´ºÄ³½½º´

Á¦7Àå °¡±Ý¿ë ¹é½Å ½ÃÀå : ±â¼úº°

  • ¼Ò°³
  • ºÒȰ¼ºÈ­
  • »ý ¾àµ¶È­ ¹é½Å
  • ÀçÁ¶ÇÕ
  • Åå¼ÒÀ̵å

Á¦8Àå °¡±Ý¿ë ¹é½Å ½ÃÀå : Á¦Çüº°

  • ¼Ò°³
  • µ¿°á°ÇÁ¶
  • ¾×ü

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °¡±Ý¿ë ¹é½Å ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Adnimalis Group
  • Anicon Labor GmbH
  • Bayer AG
  • Biovac Ltd.
  • Biovet Private Limited
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • Life Circle Nutrition AG
  • Medicavet
  • Merck & Co., Inc.
  • Nutriment Health Pty. Ltd.
  • Phibro Animal Health Corporation
  • Qilu Animal Health Products Co., Ltd.
  • Virbac Group
  • Zoetis Inc.
JHS 24.12.04

The Poultry Vaccine Market was valued at USD 2.07 billion in 2023, expected to reach USD 2.23 billion in 2024, and is projected to grow at a CAGR of 7.86%, to USD 3.51 billion by 2030.

The scope of the poultry vaccine market encompasses the development, production, and distribution of vaccines aimed at preventing infectious diseases in poultry, such as avian influenza, Newcastle disease, and infectious bronchitis. These vaccines are critical for ensuring poultry health, enhancing food security, and supporting the economic stability of the poultry industry. The necessity for poultry vaccines is underscored by the high susceptibility of poultry to infectious diseases that can lead to significant economic losses and compromise food supplies. The application of these vaccines is widespread, with end-use markets spanning across commercial poultry farms, hatcheries, and veterinary clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 2.07 billion
Estimated Year [2024] USD 2.23 billion
Forecast Year [2030] USD 3.51 billion
CAGR (%) 7.86%

Key growth factors for this market include increasing incidences of poultry diseases, growing demand for poultry as a protein source, and advancements in vaccine delivery technologies such as recombinant vaccines and encapsulation methods. The latest opportunities arise from increased emphasis on biosecurity measures and the rising trend of organic farming, which requires robust disease prevention systems. Among the recommendations is the need for companies to invest in R&D for more efficient vaccines, such as those that provide broader protection and longer-lasting immunity.

Challenges hindering market growth include stringent regulatory policies, high costs associated with vaccine development, and cold chain logistics for vaccine distribution. Furthermore, emerging diseases that outpace current vaccine capabilities can also pose significant barriers.

Innovation and research should focus on developing vaccines with shorter production times and exploring novel methods like mRNA technologies, which have gained prominence in human vaccines. Additionally, automation and digital tracking systems for vaccine administration could streamline operations and improve vaccine impact assessment.

The poultry vaccine market is dynamic, characterized by a high level of competition and regulatory oversight. Businesses that innovate in vaccine development and utilize emerging technologies and data analytics are well-positioned to achieve sustainable growth in this essential sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Poultry Vaccine Market

The Poultry Vaccine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of animal diseases
    • Surge in awareness on animal vaccination globally
    • Rising consumption of poultry protein worldwide
  • Market Restraints
    • Availability of counterfeit medicine
  • Market Opportunities
    • Technological advancements for vaccine manufacturing
    • Ongoing aim to increase food safety coupled with favorable government initiatives
  • Market Challenges
    • Strict regulatory approval and compliance concerns
    • High cost of veterinary testing and services

Porter's Five Forces: A Strategic Tool for Navigating the Poultry Vaccine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Poultry Vaccine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Poultry Vaccine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Poultry Vaccine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Poultry Vaccine Market

A detailed market share analysis in the Poultry Vaccine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Poultry Vaccine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Poultry Vaccine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Poultry Vaccine Market

A strategic analysis of the Poultry Vaccine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Poultry Vaccine Market, highlighting leading vendors and their innovative profiles. These include Adnimalis Group, Anicon Labor GmbH, Bayer AG, Biovac Ltd., Biovet Private Limited, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Life Circle Nutrition AG, Medicavet, Merck & Co., Inc., Nutriment Health Pty. Ltd., Phibro Animal Health Corporation, Qilu Animal Health Products Co., Ltd., Virbac Group, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Poultry Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Type, market is studied across Infectious Bronchitis, Marek's Disease, and New Castle Disease.
  • Based on Technology, market is studied across Inactivated, Live Attenuated Vaccines, Recombinant, and Toxoid.
  • Based on Dosage Form, market is studied across Freeze Dried Vaccines and Liquid.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of animal diseases
      • 5.1.1.2. Surge in awareness on animal vaccination globally
      • 5.1.1.3. Rising consumption of poultry protein worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of counterfeit medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements for vaccine manufacturing
      • 5.1.3.2. Ongoing aim to increase food safety coupled with favorable government initiatives
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory approval and compliance concerns
      • 5.1.4.2. High cost of veterinary testing and services
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Poultry Vaccine Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Infectious Bronchitis
  • 6.3. Marek's Disease
  • 6.4. New Castle Disease

7. Poultry Vaccine Market, by Technology

  • 7.1. Introduction
  • 7.2. Inactivated
  • 7.3. Live Attenuated Vaccines
  • 7.4. Recombinant
  • 7.5. Toxoid

8. Poultry Vaccine Market, by Dosage Form

  • 8.1. Introduction
  • 8.2. Freeze Dried Vaccines
  • 8.3. Liquid

9. Americas Poultry Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Poultry Vaccine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Poultry Vaccine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adnimalis Group
  • 2. Anicon Labor GmbH
  • 3. Bayer AG
  • 4. Biovac Ltd.
  • 5. Biovet Private Limited
  • 6. Boehringer Ingelheim International GmbH
  • 7. Eli Lilly and Company
  • 8. Life Circle Nutrition AG
  • 9. Medicavet
  • 10. Merck & Co., Inc.
  • 11. Nutriment Health Pty. Ltd.
  • 12. Phibro Animal Health Corporation
  • 13. Qilu Animal Health Products Co., Ltd.
  • 14. Virbac Group
  • 15. Zoetis Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦